Stay updated on Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial page
- Check2 days agoChange DetectedThe page metadata shows an interface/release revision bump from v3.5.2 to v3.5.3, with no changes to the underlying ClinicalTrials.gov study content.SummaryDifference0.0%

- Check10 days agoChange Detected- Revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check17 days agoChange DetectedUpdate of the Italy location entry from Padua, Italy, 35128 to Padova, Italy, 35128.SummaryDifference0.0%

- Check24 days agoChange DetectedAdded a new resource entry for Cutaneous neuroendocrine carcinoma under the Genetic and Rare Diseases Information Center resources in the study page.SummaryDifference0.1%

- Check31 days agoChange DetectedReplaced Napoli, Italy, 80131 with Naples, Italy, 80131 in the locations section.SummaryDifference0.0%

- Check38 days agoChange DetectedA new revision tag v3.5.0 was added, replacing the previous v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial page.